Cite
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
MLA
Wulaningsih, Wahyu, et al. “Prediagnostic Serum Inflammatory Markers in Relation to Breast Cancer Risk, Severity at Diagnosis and Survival in Breast Cancer Patients.” Carcinogenesis, vol. 36, no. 10, Oct. 2015, pp. 1121–28. EBSCOhost, https://doi.org/10.1093/carcin/bgv096.
APA
Wulaningsih, W., Holmberg, L., Garmo, H., Malmstrom, H., Lambe, M., Hammar, N., Walldius, G., Jungner, I., & Van Hemelrijck, M. (2015). Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients. Carcinogenesis, 36(10), 1121–1128. https://doi.org/10.1093/carcin/bgv096
Chicago
Wulaningsih, Wahyu, Lars Holmberg, Hans Garmo, Håkan Malmstrom, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, and Mieke Van Hemelrijck. 2015. “Prediagnostic Serum Inflammatory Markers in Relation to Breast Cancer Risk, Severity at Diagnosis and Survival in Breast Cancer Patients.” Carcinogenesis 36 (10): 1121–28. doi:10.1093/carcin/bgv096.